US 7838517
Compounds useful as protein kinase inhibitors
granted A61KA61K31/55A61K31/551
Quick answer
US patent 7838517 (Compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/55, A61K31/551, A61K45/06, A61P